117
Participants
Start Date
May 31, 2008
Primary Completion Date
October 31, 2008
Study Completion Date
October 31, 2008
Darifenacin
Darifenacin tablets 15 mg once daily
Tolterodine
Tolterodine extended release (ER) 4 mg once daily
Placebo
Placebo tablet once daily
Investigative Site, Phoenix
Investigative Site, Tempe
Investigative Site, Little Rock
Investigative Site, San Diego
Investigative Site, Washington D.C.
Investigative Site, Fort Myers
Investigative Site, Jacksonville
Investigative Site, Jupiter
Investigative Site, Miami
Investigative Site, Orlando
Investigative Site, Overland Park
Investigative Site, Topeka
Investigative Site, Riverdale
Investigative Site, Wellesley Hills
Investigative Site, Springfield
Investigative Site, Hackensack
Investigative Site, Burlington
Investigative Site, Greensboro
Investigative Site, Oklahoma City
Investigative Site, Knoxville
Investigative Site, Morgantown
Lead Sponsor
Procter and Gamble
INDUSTRY
Novartis
INDUSTRY